Literature DB >> 31028225

Malnutrition and Survival - Bioimpedance Data in Head Neck Cancer Patients.

Judith Büntzel1, Oliver Micke2, Klaus Kisters2, Jens Büntzel2,3, Ralph Mücke2.   

Abstract

BACKGROUND/AIM: Bioimpedance analysis (BIA) reflects the nutritional status of patients. The aim of this study was to examine whether BIA is able to document the possible impact of malnutrition on survival.
MATERIALS AND METHODS: The registered data of 42 head and neck cancer patients were analyzed. Survival data of 22 women and 20 men were included. The mean age was 67.3±10.77 years. BIA was measured by the Biocorpus 4000 RX (MEDIcal Health Care GmbH Karlsruhe) and summarized in individual phase angle (PA) of each patient.
RESULTS: Patients with normal PA>5.0 had a significantly better survival (p=0.016). The median survival time was 13.84 months (range=0.69-125.19 months) in malnourished patients (PA<5.0) compared to 51.16 months (range=7.02-116.79 months) in normally nourished head and neck cancer (HNC) patients (PA>5.0). Age adjusted body mass index had a similar impact on prognosis, but was not statistically significant (p=0.068) in the investigated study groups.
CONCLUSION: BIA is able to document the impact of malnutrition on the survival of head and neck cancer patients. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Malnutrition; bioimpedance analysis; body mass index; head and neck cancer; prognosis

Mesh:

Year:  2019        PMID: 31028225      PMCID: PMC6559905          DOI: 10.21873/invivo.11567

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  2 in total

Review 1.  [Nutritional aspects of the palliative care of head and neck cancer patients].

Authors:  J Büntzel; K Kratzing; H Joch; H Büntzel
Journal:  HNO       Date:  2020-07       Impact factor: 1.284

2.  Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy.

Authors:  Aaron J Grossberg; Crosby D Rock; Jared Edwards; Abdallah S R Mohamed; Debra Ruzensky; Angela Currie; Patricia Rosemond; Jack Phan; G Brandon Gunn; Steven J Frank; William H Morrison; Adam S Garden; Clifton D Fuller; David I Rosenthal
Journal:  Radiother Oncol       Date:  2021-03-15       Impact factor: 6.901

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.